Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal
31 August 2018
Former Executive Director of Melanoma Institute Australia Professor John Thompson has been awarded the prestigious 2018 RPA Foundation Research Medal for his outstanding contribution to melanoma treatment and research.
“I've won some medals in my time but this is undoubtedly the high point,” he said. Professor Thompson's illustrious career included 18 years at the helm of the former Sydney Melanoma Unit and now MIA, changing the face of melanoma treatment around the world. He most recently chaired the Working Group leading the updating of the Melanoma Clinical Care Guidelines.
Professor Thompson is only the second surgeon to take out the award. He was instrumental in the development, description, and refinement of the isolated limb infusion technique for patients with advanced limb cancers. He has made an enormous contribution to advances in melanoma treatment and has influenced breakthrough developments in the melanoma landscape.
For RPA’s Director of Research, Warwick Britton, Professor Thompson has been a game changer.
"His approach has changed the paradigm of management of melanoma surgery.”
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.